In the current study, we tried to study the expression of LGALS3 and LGALS3BP, their potential as prognostic markers and the possible genetic/epigenetic mechanism underlying their dysregulation in different subtypes of glioblastoma (GBM), by using large online databases. This evidence concerns the gene LGALS3BP and glioblastoma.